CG Oncology (CGON) Fair Value & DCF
Score
CGON fair value $45.41. Price $84.78. Price is 87% above fair value.
Worked example
Cash-flow value. Starting free cash flow is $0.02 a share. Years 1 to 5 grow at 20.00%. Years 6 to 10 fade that rate in a straight line to 3% terminal growth. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $0.99 a share.
Earnings value. Next-twelve-months earnings per share of $3.15 times 28.50 is $89.82. The peer group is Biotechnology, 13 companies worth at least $10 billion. This stock has no 10-year median P/E, so the peer median of 28.5 is kept between 8 and 30, which is 28.50.
Fair value is the average of the two, $45.41. The price is $84.78, which is 86.7% above fair value.